Harbour Investments, Inc. Adaptive Biotechnologies Corp Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$25.17 - $36.85 $30,556 - $44,735	-1,214 Reduced 91.9%	107 $3,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $249,796 - $331,758	-8,321 Reduced 86.3%	1,321 $45,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $14,499 - $20,065	450 Added 4.9%	9,642 $394,000
Q1 2021 Aug 17, 2021	BUY	$37.26 - $67.74 $258,845 - $470,589	6,947 Added 309.44%	9,192 $370,000
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $83,648 - $152,076	2,245 New	2,245 $90,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.